Krystal Biotech, Inc. financial data

Symbol
KRYS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2100 Wharton Street, Suite 701, Pittsburgh, PA
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 19, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 881 % -47.5%
Quick Ratio 22 %
Debt-to-equity 9.76 % +77.4%
Return On Equity 10.3 % +529%
Return On Assets 9.36 % +504%
Operating Margin 22.6 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28.8M shares
Common Stock, Shares, Outstanding 28.8M shares +1.97%
Entity Public Float 4.6B USD +64.3%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 28.6M shares +5.3%
Weighted Average Number of Shares Outstanding, Diluted 29.7M shares +7.16%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 291M USD +473%
Research and Development Expense 53.6M USD +15.4%
General and Administrative Expense 93.9M USD +67.1%
Operating Income (Loss) 65.7M USD +1219%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 29.8M USD -63.1%
Income Tax Expense (Benefit) 2.59M USD
Net Income (Loss) Attributable to Parent 89.2M USD +716%
Earnings Per Share, Basic 3.12 USD/shares +680%
Earnings Per Share, Diluted 3 USD/shares +669%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 345M USD -3.76%
Cash, Cash Equivalents, and Short-term Investments 598M USD +12.3%
Accounts Receivable, after Allowance for Credit Loss, Current 105M USD +149%
Inventory, Net 26.5M USD +279%
Assets, Current 742M USD +26.2%
Property, Plant and Equipment, Net 155M USD -3.74%
Operating Lease, Right-of-Use Asset 6.28M USD -10.6%
Other Assets, Noncurrent 231K USD -12.2%
Assets 1.06B USD +29%
Accounts Payable, Current 4.99M USD +20.6%
Liabilities, Current 102M USD +208%
Operating Lease, Liability, Noncurrent 6.04M USD -8.7%
Other Liabilities, Noncurrent 1.42M USD
Liabilities 109M USD +176%
Accumulated Other Comprehensive Income (Loss), Net of Tax -190K USD -130%
Retained Earnings (Accumulated Deficit) -181M USD +33%
Stockholders' Equity Attributable to Parent 946M USD +21.5%
Liabilities and Equity 1.06B USD +29%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 15.9M USD
Net Cash Provided by (Used in) Financing Activities 10.6M USD +618%
Net Cash Provided by (Used in) Investing Activities -26M USD -829%
Common Stock, Shares Authorized 80M shares 0%
Common Stock, Shares, Issued 28.8M shares +1.97%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 678K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 345M USD -3.76%
Deferred Tax Assets, Valuation Allowance 68.1M USD -11.6%
Deferred Tax Assets, Gross 83.1M USD -9.24%
Operating Lease, Liability 7.26M USD -10.3%
Depreciation 5.97M USD +19.2%
Payments to Acquire Property, Plant, and Equipment 1.26M USD -76.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 88.3M USD +618%
Lessee, Operating Lease, Liability, to be Paid 14.6M USD -9.53%
Property, Plant and Equipment, Gross 177M USD +1.76%
Operating Lease, Liability, Current 1.22M USD -17.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.28M USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.28M USD -17%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.36M USD -8.76%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.3M USD +1.8%
Deferred Tax Assets, Operating Loss Carryforwards 14.5M USD -63.6%
Unrecognized Tax Benefits 4.15M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.33M USD +1.92%
Additional Paid in Capital 1.13B USD +7.58%
Deferred Tax Assets, Net of Valuation Allowance 15M USD +3.03%